Mouth Opening, Prevention, Education, Nutrition (OPEN)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients
- Status
- COMPLETED
- Phase
- NA
MRI - Guided Adaptive RadioTHerapy for Reducing XerostomiA in Head and Neck Cancer (MARTHA-trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Preoperative Nutritional Intervention in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- NA
Lymph Drainage Mapping for Tailoring Elective Nodal Irradiation in Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Deciphering Mechanisms Underlying Cancer Immunogenicity
- Status
- RECRUITING
- Phase
- NA
Evaluation of the Automatic Deformable Recontouring on the Daily MVCT for Head and Neck Cancer Adaptive Radiotherapy
- Status
- WITHDRAWN
- Phase
- NA
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology
- Status
- COMPLETED
- Phase
- NA
Cell-free Tumor DNA in Head and Neck Cancer Patients
- Status
- UNKNOWN
- Phase
- NA
Abemaciclib and Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE2
MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour
- Status
- UNKNOWN
- Phase
- PHASE1
Patient-Reported Outcomes in Head and Neck Cancer
- Status
- RECRUITING
- Phase
- NA
NUTRI-HAB - Posttreatment Rehabilitation of Nutrition Impact Symptoms in Head and Neck Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers
- Status
- RECRUITING
- Phase
- N/A
Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Eating Difficulties in HNC Patients - Influencing Factors and Short and Long Term Impacts on PF and Depression
- Status
- COMPLETED
- Phase
- N/A
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN
- Status
- COMPLETED
- Phase
- PHASE2